These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36101800)

  • 21. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
    Onishi H; Murakami T; Kim T; Hori M; Iannaccone R; Kuwabara M; Abe H; Nakata S; Osuga K; Tomoda K; Passariello R; Nakamura H
    Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.
    Maruyama H; Takahashi M; Ishibashi H; Yoshikawa M; Yokosuka O
    Br J Radiol; 2012 Apr; 85(1012):351-7. PubMed ID: 21224305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.
    Sun XL; Yao H; Men Q; Hou KZ; Chen Z; Xu CQ; Liang LW
    World J Gastroenterol; 2017 Aug; 23(30):5602-5609. PubMed ID: 28852319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
    Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
    Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
    Xu R; Wang J; Huang X; Zhang Q; Xie Y; Pang L; Bai L; Zhou J
    J BUON; 2019; 24(4):1429-1434. PubMed ID: 31646787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
    Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
    Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
    Huang Z; Wu X; Li S; Li K
    Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer.
    Kong Y; Jing Y; Sun H; Zhou S
    J Healthc Eng; 2022; 2022():5074571. PubMed ID: 35237392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.